• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume7, Issue7

Biomarkers of Tuberculosis – A Review

    Ritika sharma

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 4851-4867

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

According to recent World Health Organization reports, Tuberculosis is regarded to be the most severe disease caused by infection. There are significant drawbacks to the testing used for TB diagnosis and there is no accurate point-of-care (POC) diagnostic examination. New methods are required worldwide to controlling tuberculosis (TB). In general, new diagnostic methods and new biomarkers are necessary to assess both pathogenic and host main elements of an infection response. Biomarker-based or multiple marker biosignature-based tests, preferably conducted on blood or urine, for the identification of active TB may help achieve the target drug profiles recommended for point-of-care testing by the World Health Organization. Here I review The identified forms of biomarkers included antibodies, cytokines, metabolic markers, mycobacterial antigens and volatile organic compounds and the different biomarkers of tuberculosis, like,LAM ,IFN-g ,myolic acid ,antigen 85,different VOCs,Rv1681 protein,CFP-10,granzyme A
Keywords:
    antigen 85 neopterin granzyme A mycolic acid LAM
  • PDF (478 K)
  • XML
(2020). Biomarkers of Tuberculosis – A Review. European Journal of Molecular & Clinical Medicine, 7(7), 4851-4867.
Ritika sharma. "Biomarkers of Tuberculosis – A Review". European Journal of Molecular & Clinical Medicine, 7, 7, 2020, 4851-4867.
(2020). 'Biomarkers of Tuberculosis – A Review', European Journal of Molecular & Clinical Medicine, 7(7), pp. 4851-4867.
Biomarkers of Tuberculosis – A Review. European Journal of Molecular & Clinical Medicine, 2020; 7(7): 4851-4867.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 30
  • PDF Download: 80
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus